These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 8252577)
1. Approaches to the development of selective inhibitors of vascular smooth muscle cell proliferation. Weissberg PL; Grainger DJ; Shanahan CM; Metcalfe JC Cardiovasc Res; 1993 Jul; 27(7):1191-8. PubMed ID: 8252577 [TBL] [Abstract][Full Text] [Related]
2. Hexamethylenebisacetamide selectively inhibits the proliferation of human and rat vascular smooth-muscle cells. Grainger DJ; Hesketh TR; Weissberg PL; Metcalfe JC Biochem J; 1992 Apr; 283 ( Pt 2)(Pt 2):403-8. PubMed ID: 1575685 [TBL] [Abstract][Full Text] [Related]
3. Heparin decreases the rate of proliferation of rat vascular smooth muscle cells by releasing transforming growth factor beta-like activity from serum. Grainger DJ; Witchell CM; Watson JV; Metcalfe JC; Weissberg PL Cardiovasc Res; 1993 Dec; 27(12):2238-47. PubMed ID: 8313434 [TBL] [Abstract][Full Text] [Related]
4. Heparin fails to inhibit the proliferation of human vascular smooth muscle cells in the presence of human serum. Underwood PA; Mitchell SM; Whitelock JM J Vasc Res; 1998; 35(6):449-60. PubMed ID: 9858870 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms of vascular smooth muscle cell proliferation. Weissberg PL Ann Acad Med Singap; 1991 Jan; 20(1):38-42. PubMed ID: 2029162 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of protein synthesis and antiproliferative effect of the angiotensin converting enzyme inhibitor trandolaprilat in rat vascular smooth muscle cells. Uehara Y; Numabe A; Kawabata Y; Takada S; Hirawa N; Nagata T; Ikeda T; Yagi S; Omata M J Hypertens; 1993 Oct; 11(10):1073-81. PubMed ID: 8258671 [TBL] [Abstract][Full Text] [Related]
7. Effects of combined endothelin and angiotensin II antagonism on growth factor-induced proliferation of vascular smooth muscle cells isolated from uremic rats. Wolf SC; Sauter G; Risler T; Brehm BR Ren Fail; 2005; 27(4):465-74. PubMed ID: 16060137 [TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta 1 proliferated vascular smooth muscle cells from spontaneously hypertensive rats. Sato M; Ohsaki Y; Tobise K Am J Hypertens; 1995 Feb; 8(2):160-6. PubMed ID: 7755944 [TBL] [Abstract][Full Text] [Related]
9. Proliferation of human aortic vascular smooth muscle cells in culture is modulated by active TGF beta. Kirschenlohr HL; Metcalfe JC; Weissberg PL; Grainger DJ Cardiovasc Res; 1995 Jun; 29(6):848-55. PubMed ID: 7656289 [TBL] [Abstract][Full Text] [Related]
10. Decreased susceptibility of cultured smooth muscle cells from SHR rats to growth inhibition by heparin. Resink TJ; Scott-Burden T; Baur U; Bürgin M; Bühler FR J Cell Physiol; 1989 Jan; 138(1):137-44. PubMed ID: 2910881 [TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation. Virone-Oddos A; Desangle V; Provost D; Cazes M; Caussade F; Cloarec A Br J Pharmacol; 1997 Feb; 120(3):488-94. PubMed ID: 9031754 [TBL] [Abstract][Full Text] [Related]